Lukáš Bajer (Lukas Bajer)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Mesenchymal Stem Cells

Randomized Controlled Trial

Transforming Growth Factor

Ejection Fraction

Top Venues

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jan Březina, Lukáš Bajer, Pavel Wohl, Dana Ďuricová, Pavel Hrabák, Aleš Novotný, Jana Koželuhová, Milan Lukáš, Jakub Mrázek, Kateřina Olša Fliegerová, Simona Kvasnová, Chahrazed Mekadim, Jan Mares, Julius Špičák, Pavel Drastich
Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis-Results of a Randomized Controlled Trial. Journal of clinical medicine 10 (13) (2021)
Dagmar Schierova, Radka Roubalova, Martin Kolar, Zuzana Stehlikova, Filip Rob, Zuzana Jackova, Stepan Coufal, Tomas Thon, Martin Mihula, Martin Modrák, Miloslav Kverka, Lukáš Bajer, Klara Kostovcikova, Pavel Drastich, Jana Hercogova, Michaela Novakova, Martin Vasatko, Milan Lukas, Helena Tlaskalova-Hogenova, Zuzana Jiraskova Zakostelska
Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy. Cells 10 (11) (2021)
Dagmar Schierová, Jan Březina, Jakub Mrázek, Kateřina Olša Fliegerová, Simona Kvasnová, Lukáš Bajer, Pavel Drastich
Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy. Cells 9 (10) (2020)
Stepan Coufal, Natalie Galanova, Lukáš Bajer, Zuzana Gajdarova, Dagmar Schierova, Zuzana Jiraskova Zakostelska, Klara Kostovcikova, Zuzana Jackova, Zuzana Stehlikova, Pavel Drastich, Helena Tlaskalova-Hogenova, Miloslav Kverka
Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response. Cells 8 (7) (2019)